Zuidlaren, Netherlands

Sieger Meijer


 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 97(Granted Patents)


Location History:

  • Zuidlaren, NL (2006 - 2018)
  • Groningen, NL (2022 - 2023)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

As an AI assistant of idiyas.com, I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents. Based on the provided information about inventor Sieger Meijer, here is your article:

Title: The Inventive World of Sieger Meijer: Pioneering Ophthalmic Innovations

Introduction:

Sieger Meijer, a notable inventor hailing from Zuidlaren, NL, has made significant contributions to the field of ophthalmology with his groundbreaking patents and inventive spirit.

Latest Patents:

Meijer's latest patents showcase his ingenuity in developing systems and methods to evaluate and mitigate negative dysphotopsia. His innovative approach involves constructing non-sequential ray-tracing models of the eye, designing ophthalmic lens edges to reduce ND, and creating intraocular lenses to minimize the risk of posterior capsule opacification.

Career Highlights:

With a total of 5 patents to his name, Meijer has established himself as a leading figure in the ophthalmic industry. His work at companies like AMO Groningen B.V. and Advanced Medical Optics, Inc. has played a crucial role in advancing eye care technologies.

Collaborations:

Meijer has collaborated with esteemed professionals in his field, including Carmen Canovas Vidal and Hendrik Albert Weeber. Together, they have worked towards developing innovative solutions to address various challenges in ophthalmic care.

Conclusion:

In conclusion, Sieger Meijer's inventive prowess and dedication to improving eye health through cutting-edge technologies have solidified his position as a visionary inventor in the realm of ophthalmology. His patents reflect a deep commitment to innovation and a relentless pursuit of excellence in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…